Cabaletta Bio Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Rule 10b5-1 Trading Plans
During the fiscal quarter ended on March 31, 2024, none of our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted, modified orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation S-K, except as described in the table below:
| Name and Title | Action | Action Date | Duration of Trading Arrangements(1) | Rule 10b5-1 Trading Arrangement?(Y/N)* | Aggregate Number of Securities Subject to Trading Arrangement |
|---|---|---|---|---|---|
| Michael GerardGeneral Counsel | Adopt | February 21, 2024 | August 1, 2024 – August 6, 2025 | Y | Up to 46,875 shares to be sold |
- Denotes whether the trading plan is intended, when adopted, to satisfy the affirmative defense of Rule 10b5-1(c).
(1) Except as indicated by footnote, each trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.